Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kelly Biette"'
Autor:
Kelly Biette, Michael A. Davies, J.-J. Grob, Paul Nathan, Mario Mandalà, Hiya Banerjee, John M. Kirkwood, Dirk Schadendorf, Mike Lau, Aislyn Boran, Caroline Robert, Axel Hauschild, Reinhard Dummer, B.G. Sahoo, Georgina V. Long
Publikováno v:
Annals of Oncology. 32:S891-S892
Autor:
Hussein Abdul-Hassan Tawbi, Victoria Atkinson, Paul Nathan, Naoya Yamazaki, Radha Ramesh, Daniel Gusenleitner, Paolo A. Ascierto, Céleste Lebbé, Eduard Gasal, Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Jan C. Brase, Keith T. Flaherty, Georgina V. Long, Mario Mandalà, Antoni Ribas, Kelly Biette, Erika Richtig, Ana Arance
10034 Background: Spartalizumab + dabrafenib + trametinib has previously shown a high response rate of 78% (28 of 36 pts), with a complete response (CR) rate of 42%. A correlative analysis of gene expression signatures (GES)/pathways using whole-tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4427df5cbb6f0c621237dae3895445f3
Autor:
Thomas Hengelage, Melissa Lynne Johnson, Daniel Shao-Weng Tan, Debbie Robbrecht, Helena Alexandra Yu, Kun Xu, Maria Jove, Geoffrey I. Shapiro, Irene Brana, Kelly Biette, Hironobu Minami, Lillian L. Siu, Eugene Tan, Neeltje Steeghs, Susan Moody
Publikováno v:
Journal of Clinical Oncology. 39:3005-3005
3005 Background: SHP2 transduces signals from activated receptor tyrosine kinases to downstream pathways including MAPK. TNO155 is a selective, allosteric, oral inhibitor of SHP2. Methods: CTNO155X2101 (NCT03114319) is an ongoing first-in-human, open